Remove Artificial Inteligence Remove Course Remove Screening Remove Venture Capital
article thumbnail

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem?s Approval & More

Xconomy

ASCO 2020 won’t be the Windy City gathering it usually is, but drug and diagnostics developers are still raring to share fresh data from their efforts in cancer immunotherapy, targeted treatments, and early-stage screening methods during the course of the three-day scientific program. While oncology.

article thumbnail

Dealing With Generational Change at VC Firms

Both Sides of the Table

The interview was wide ranging and discussed everything from USVs investment thesis over the past 10 years to what some emerging themes are around blockchain and artificial intelligence. Dan asked Fred about “generational change” at USV and in the VC industry more broadly. ” And we did.

article thumbnail

The Coming Shift in Enterprise Software

Both Sides of the Table

The trailblazer in the category of course was Twitter and David Sacks quickly spotted the use case for enterprise and launched Yammer, which was purchased by Microsoft for more than $1 billion. And of course we welcome Microsoft Ventures. Tact is a pioneer in using chat-based communications as a computing metaphor.

Software 105